Ranbaxy Q1 net dips 90% to Rs 126 cr

Tags: Companies
Drug major Ranbaxy Laboratories today posted a 89.91 per cent decline in its consolidated net profit at Rs 125.75 crore for the first quarter ended March 31, 2013.

The company had posted a net profit of Rs 1,246.76 crore in the same period of previous year.

Net sales of the company declined to Rs 2,439.82 crore for the January-March quarter, compared to Rs 3,708.97 crore in the same period of 2012, Ranbaxy Laboratories Ltd said in a filing to the BSE.

Shares of Ranbaxy were trading at Rs 445 on the BSE in late afternoon trade, down 2.52 per cent from its previous close.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • With a saffron censor, freedom of filmmakers is in grave danger

    The composition of the Central Board of Film Certification (CBFC), recently reconstituted in the wake of the en bloc resignation of the previous panel

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India

COLUMNIST

Varun Dutt

<b>Riskfactor</b>: 'Fool'-filled method

The gambler’s fallacy, also known as the Monte Carlo fallacy, ...

Zehra Naqvi

Style must reflect a book’s content

Pakistani writer Bilal Tanweer talks about his book, The Scatter ...

Bubbles Sabharwal

Perfection is a myth

I meet a lot of young people in my line ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture